Authors:
Malaguarnera, M
Di Fazio, I
Trovato, BA
Pistone, G
Mazzoleni, G
Citation: M. Malaguarnera et al., Alpha-interferon (IFN-alpha) treatment of chronic hepatitis C: analysis ofsome predictive factors for the response, INT J CL PH, 39(6), 2001, pp. 239-245
Authors:
Malaguarnera, M
Ferlito, L
Gulizia, G
Di Fazio, I
Pistone, G
Citation: M. Malaguarnera et al., Use of interleukin-2 in advanced renal carcinoma: meta-analysis and reviewof the literature, EUR J CL PH, 57(4), 2001, pp. 267-273
Authors:
Malaguarnera, M
Di Fazio, I
Ferlito, L
Pistone, G
Laurino, A
Vinci, E
Mazzoleni, G
Citation: M. Malaguarnera et al., Increase of serum beta 2-microglobulin in patients affected by HCV correlated hepatocellular carcinoma, EUR J GASTR, 12(8), 2000, pp. 937-939
Authors:
Malaguarnera, M
Restuccia, S
Di Fazio, I
Zoccolo, AM
Ferlito, L
Bentivegna, P
Citation: M. Malaguarnera et al., Serum carnitine levels in chronic hepatitis C patients before and after lymphoblastoid interferon-alpha treatment, BIODRUGS, 12(1), 1999, pp. 65-69
Authors:
Malaguarnera, M
Restuccia, N
Di Fazio, I
Panebianco, MP
Gulizia, G
Giugno, I
Citation: M. Malaguarnera et al., Fish oil treatment of interferon-alpha-induced dyslipidaemia: Study in patients with chronic hepatitis C, BIODRUGS, 11(4), 1999, pp. 285-291
Authors:
Malaguarnera, M
Restuccia, S
Di Fazio, I
Di Marco, R
Pistone, G
Trovato, BA
Citation: M. Malaguarnera et al., Rapid evolution of chronic viral hepatitis into hepatocellular carcinoma after beta-interferon treatment, PANMIN MED, 41(1), 1999, pp. 59-61